Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Amita Kulkarni"'
Autor:
Amita Kulkarni, Adrian Chiem, Kamaljeet Singh, Cara Mathews, Paul A. DiSilvestro, Lindsey Beffa
Publikováno v:
Gynecologic Oncology Reports, Vol 37, Iss , Pp 100856- (2021)
Externí odkaz:
https://doaj.org/article/03d246577b7f47039dcb8ba763bb8f59
Publikováno v:
International Journal of Gynecologic Cancer. 33:57-65
ObjectiveThis study aimed to identify whether frailty is associated with the time between surgery and the initiation of chemotherapy for patients with ovarian cancer.MethodsThis retrospective cohort study included patients 18 years or older with stag
Autor:
Jordan, Mattson, Jenna, Emerson, Amelia, Underwood, Grace, Sun, Sarah L, Mott, Amita, Kulkarni, Katina, Robison, Emily K, Hill
Publikováno v:
Gynecologic Oncology. 166:465-470
The objective of this study was to compare the rate of groin recurrence among women undergoing superficial or deep inguinal lymph node dissections in suspected early-stage vulvar carcinoma. Secondary objectives included comparison of overall survival
Sexual health and function among patients receiving systemic therapy for primary gynecologic cancers
Autor:
Amita Kulkarni, Grace Sun, Sarah Manuppelli, Heidy Mendez, Jocelyn Rezendes, Christine Marin, Christina A. Raker, Katina Robison
Publikováno v:
Gynecologic Oncology. 165:323-329
Sexual dysfunction has been reported after gynecologic cancer treatment but few studies have examined sexual function during treatment. Our objectives were to describe sexual function among women receiving systemic therapy for gynecologic cancers and
Autor:
Amita Kulkarni, Shannon Glynn, Charlotte R. Gamble, Megan Johnson Shen, Evelyn Cantillo, Melissa K. Frey, Kevin M. Holcomb, Monika M. Safford, Eloise Chapman-Davis
Publikováno v:
Journal of lower genital tract disease. 27(1)
Loss to follow-up after abnormal cervical cancer screening disproportionately impacts underserved populations. Our objective was to identify perceived barriers to follow-up after abnormal Pap smear among underserved women.Women with abnormal Pap smea
Publikováno v:
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 42
Nearly 3% of the population carries genetic variants that lead to conditions that include hereditary breast and ovarian cancer and Lynch syndrome. These pathogenic variants account for approximately 20% of ovarian cancer cases, and those with germlin
Autor:
Amita Kulkarni, Muhammad Danyal Ahsan, Katherine Vasquez, Ngozi Monu, Xiaoyue Ma, Paul Christos, Melissa Frey, Kevin Holcomb, Evelyn Cantillo, Eloise Chapman-Davis
Publikováno v:
Gynecologic Oncology. 166:S148-S149
Publikováno v:
American journal of obstetrics and gynecology. 226(4)
Publikováno v:
Journal of Clinical Oncology. 40:211-211
211 Background: Patients with BRCA1/2 pathogenic variants have an elevated risk for several malignancies including breast and ovarian cancer. Recommended risk-reducing treatments and surgeries can cause sexual dysfunction. Yet, sexual health is often
Publikováno v:
Gynecologic Oncology Reports, Vol 37, Iss, Pp 100856-(2021)
Gynecologic Oncology Reports
Gynecologic Oncology Reports
Highlights • Mesonephric carcinomas are rare cancers that arise from mesonephric remnants. • Mesonephric-like carcinomas are similar but with mesonephric differentiation. • These cases add to the limited literature of these separate but similar